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cytochrome P450 family and the glu-
tathione S-transferase-are now well
known from both human and animal
studies to play an important role in the
metabolism ofcarcinogens.
* A better understanding of the potential
differences in a tumor suppressor gene
pathway in chemically induced and
spontaneous kidney cancer.
* An understanding ofthe different capaci-
ties ofcells for DNA repair. Two types of
DNA repair exist: repair pathways and a
tolerance mechanism. In repair mecha-
nism, the DNA damage is removed, while
tolerance mechanism circumvents the
damagewithout fixing it.
* Increased information on the role ofvirus-
es in caricinogenesis. For example, recent
reports describe how an adenovirus that
has a key gene deleted can no longer
reproduce itself in normal cells, but does
just fine in cancer cells lacking the p53
tumor suppressor gene. As a result, the
virus kills the cancer cell, apparentlywith-
outharming the normal cells.
* Advances in our knowledge of signal
transduction that have led to major
insights into the fundamental pathway
that govern growth regulation of cells.
These discoveries fulfill the long-sought
ability to delineate a sequence of events
from extracellular signals to nuclear
responses. Additionally, key molecules in
the pathway are evolutionarily conserved
and mediated in an eclectic array ofsig-
nals. Alterations in the pathway are
important in tumorigenesis and tumor
progression.
* Discovery that apoptosis-programmed
cell death-is highly regulated at the
molecular level by oncogenes and anti-
oncogenes. Understanding thebiochemical
and molecular pathway that controls
apoptosis is central to the cancerproblem.
* The characterization of the relationship
between peroxisome proliferators and can-
cer, including the role of cell receptors,
DNAoxidation, andgene expression.
* Abetter understanding ofthe mechanism
through which the leukemogen benzene
affects bone marrow. Metabolites ofben-
zene are found to be highly concentrated
in bone marrow ofexposed animals.
* The elucidation of generic mechanisms
of action common to multiple chemi-
cals. These studies have included
nitroaromatic compounds, automotive
fuels, dioxin, butadiene, chloroform and
chlorine, dimethylamine, ethylene oxide,
and furans.
* Increased expertise in the development
of methods for conducting carcinogenic
studies, including numerous assays and
techniques in a range ofdisciplines.
In 1996, there was evidence of high
momentum in both privately funded and
government supported research aimed at
better understanding risks to human health
from exposure to environmental agents.
Clearly, environmental health research
including risk assessment science is at a
remarkable point in time. There is awonder-
ful record of accomplishments, and this
accounting is only a partial list. There has
been enormous progress against cancer, yet
so much more remains to bedone in improv-
ing the basis for understanding and assessing
potential adverse effects of chemicals and
consumerproducts onhumanhealth.
The more we know about the mecha-
nisms involved in environmental chemical
interactions with complex mammalian
organisms, including both laboratory ani-
mals and humans, the more confident the
public will become in estimates of human
health risks, and the firmer the scientific
foundation for environmental health policy
formulation will become for the prevention
and control of cancer and related diseases,
dysfunction, and premature death. This
policyand the related regulations and inter-
vention programs shape our society and
suggest priorities for investment ofpublic
health resources. The importance of these
issues cannot be overstated, and the EPA
appears to be moving in the right direction.
BailusWalker
Howard University Cancer Center
Washington, D.C.
Responsible Care and the
Third World
As you point out, many environmental
health scientists remain skeptical that the
chemical industry's Responsible Care ini-
tiative is mainly a public relations ploy to
improve the industry's dismal public image
[EHP 104:1138(1996)]. Nowhere is the
challenge greater than in the rapidly indus-
trializing countries of the Third World,
where corporate responsibility is not com-
pelled by public awareness, regulation, and
compensation laws.
The double standards ofglobal corpora-
tions that operate more polluting and dan-
gerous plants in Third World countries were
described notonlybyindustrycritics butalso
the International Labor Office and the
United Nations Center on Transnational
Corporations (1,2). After the disaster at
Union Carbide's plant in Bhopal, India,
giant chemicalproducers based in the United
States and Europe have been obliged to issue
policy statements to the effect that they do
not have lower standards for the protection
ofhuman health and safety and the environ-
ment in theirThirdWorld operations.
When pressed, however, leading firms
have been reluctant to disclose toxic release
inventory data for pollution from their for-
eign plants as they have had to do by law in
the United States since 1988. Similarly, U.S.
law requires a process hazards analysis in the
event of failure ofsafety systems, including
worst-case accident scenarios-are the big
companies willing to release similar analyses
for their affiliates' plants in Africa, Asia, and
Latin America? What about meeting mod-
ern standards for disposal of hazardous
wastes from plants located in countries with
no facilities available for disposing of these
wastes in a manner that would meet the
standards the companies face in Europe and
North America? Where a control limit is
opposed by a corporation as unnecessarily
strict, does the company comply with the
limit outside the country where the limit is
in effect but being challenged in court? Ifa
pesticide is banned for certain uses or volun-
tarilywithdrawn from markets in the United
States, does that mean it will be similarly
withdrawn elsewhere? If teratogenic glycol
ether solvents are withdrawn from uses in
the United States because ofliability consid-
erations, will they be withdrawn from sale in
other countrieswhere no suchliability exists?
Product stewardship is the most chal-
lenging area that the chemical corporations
have tried to address through the
Responsible Care initiative. But closerexam-
ination has shown that, in 1991, DuPont's
putative product stewards were none other
than the company's sales representatives.
Obviously salespeople have neither the
incentive nor the training to critically evalu-
ate the industrial hygiene and pollution con-
trol measures oftheir customers.
To some extent, industry is being
forced to develop cleaner and safer process-
es and products in North America and
Europe. Will the companies who are mak-
ing these advances in some countries rapid-
ly transfer them around the world? Or will
the companies take manyyears to reformu-
late adhesives, sealants, and paints made
with toxic solvents and heavy metal pig-
ments in Third World countries?
Responsible Care does not deal with the
very sensitive subject of compensation.
Bayer has operated highly hazardous chro-
mate facilities in Mexico and South Africa
and manyworkers and members ofthe sur-
rounding communities have been harmed.
Lung cancer has been recognized as a com-
pensable occupational disease in chromate
workers in Germany since 1936, but this
was not entered in the schedule ofoccupa-
tional diseases in South Africa until 1994.
When a Natal doctor attributed some work-
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ers' lung cancer deaths to their occupation,
Bayer steadfastly refused to pay any com-
pensation. Perhaps the best way of getting
global corporations to eliminate double
standards is to have them held liable in their
home countries, as U.S. companies are for
the creation of toxic waste sites under the
Comprehensive Environmental Response,
Compensation, and LiabilityAct.
The subjects ofthis letter are dealt with
in more detail elsewhere (3). However, it is
clear that the greatest testing ground for
corporate policies on health, safety, and the
environment, and industry initiatives like
Responsible Care is the rapidly industrial-
izing countries. Public health workers
should subject the big companies' claims to
careful international scrutiny. Curbing
double standards represents both a formi-
dable challenge and a great opportunity in
environmental health.
Barry I. Castdeman
Environmental Consultant
Baltimore, Maryland
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I dMuSociety
The 28thAnnual Environmental Mutagen Society Meeting will be held at the Hyatt
Regency Hotel in Minneapolis, Minnesota,April 19-24,1997. The Environmental
Mutagen Society is an international society whose purpose is to engage in scientific
investigation and dissemination ofinformationrelating to thefield ofmutagenesis and to
encourage the study ofmutagens in the human environment, in particular how muta-
gens may affect public health. The annual meetingbrings together scientists from
academia, industry, and government to discuss recent findings in the fields of mutage-
nesis and molecular genetics and their application to regulation and safety evaluation.
For more information, please contact Sid Aaron, Pharmacia and Upjohn Inc., 301
Henrietta St., Kalamazoo, MI 49007; (616) 833-1399, Fax (616) 833-9722, email:
saaron~am.pnu.com or the EMS business office, 11250-8 Roger Bacon Dr., Suite 8,
Reston, VA 22090; (703) 437-4377, Fax (703) 435-4390, email: emsdmg~aol.com
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